MYGN Myriad Genetics, Inc.
$6.63▲ +5.41%
Healthcare
Other
After hours
$6.69▲ +0.90%
Oct 28, 7:16 PM ET
Volume 2.48M
Avg Volume (10D) 4.49M
Key Metrics & Fundamentals
Market Cap
$634.16M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.74 - 8.38
% vs 50 MA
62.46%
% vs 200 MA
44.00%
RSI-14
81.0
MACD Histogram
+0.2100
Beta (1Y vs SPY)
1.17
Free Cash Flow
-$11.50M
Gross Rev
$190.70M
Gross Profit
$127.00M
EBITDA
-$26.00M
COGS
$63.70M
Operating Exp
$165.90M
Operating Income
-$38.90M
EBIT
-$38.90M
Pretax Income
-$42.60M
Net Income
-$43.20M
EPS (Diluted)
-0.46
Price & Volume History
Loading chart…
Recent News
Labcorp inks Millennium Health buyout to add drug testing services
MedTech Dive · Oct 26, 2026 5:18 AM ET

What Quest Diagnostics (DGX) Said on Its Q3 Earnings Call
MarketBeat · Oct 22, 2026 2:04 PM ET
Myriad Genetics Says New Results Show Potential of MRD Detection in Colorectal, Pancreatic Cancers
MT Newswires · Oct 22, 2026 10:17 AM ET

Myriad Genetics (MYGN) Stock Sees Fair Value Lift After Split Analyst Revisions
Simply Wall St. · Oct 22, 2026 9:11 AM ET

Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
GlobeNewswire · Oct 22, 2026 9:05 AM ET
Labcorp to buy Myriad’s prenatal health testing unit for $210M
MedTech Dive · Oct 22, 2026 6:50 AM ET

Stocks making big moves yesterday: Washington Trust Bancorp, Doximity, Myriad Genetics, Arhaus, and Gartner
StockStory · Oct 21, 2026 3:34 PM ET
Sector Update: Healthcare Stocks Gain Late Afternoon
MT Newswires · Oct 20, 2026 3:53 PM ET

Myriad Genetics (MYGN) Stock Trades Up, Here Is Why
StockStory · Oct 20, 2026 3:41 PM ET
Sector Update: Healthcare Stocks Gain Tuesday Afternoon
MT Newswires · Oct 20, 2026 1:38 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See MYGN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.